title: [Neuroethics of pharmaceutical cognitive enhancement: the first ten years: current problems and practical guiding principles].
abstract: An evaluating survey of the development of the neuroethics of pharmaceutical cognitive enhancement (PCE) during the last decade, focussing on the situation in Germany, has been undertaken. This article presents the most important conceptual problems, current substances and central ethical and legal issues. Very first guidelines and recommendations for policy-makers are formulated at the end of the text.
authors.affiliation: Philosophisches Seminar,Johannes Gutenberg-Universität, Mainz. metzinger@uni-mainz.de
authors.forename: T K
authors.initials: TK
authors.lastname: Metzinger
mesh_terms: D035843:Biomedical Research / Q000941:ethics / Q000331:legislation & jurisprudence; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D003071:Cognition / Q000502:physiology*; D003072:Cognition Disorders / Q000175:diagnosis / Q000188:drug therapy*; D003704:Dementia / Q000188:drug therapy; D005858:Germany; D006801:Humans; D009462:Neurology / Q000941:ethics*; D018697:Nootropic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D011057:Politics; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
chemical_list: D000697:Central Nervous System Stimulants; D018697:Nootropic Agents; D017367:Selective Serotonin Reuptake Inhibitors